Abstract:Hereditary hearing impairment (HI) is a common disease with the highest incidence among sensory defects. Several genes have been identified to affect stereocilia structure causing HI, including the unconventional myosin3A. Interestingly, we noticed that variants in MYO3A gene have been previously found to cause variable HI onset and severity. Using clinical exome sequencing, we identified a novel pathogenic variant p.(Lys50Arg) in the MYO3A kinase domain (MYO3A-KD). Previous in vitro studies supported its damaging effect as a 'kinase-dead' mutant. We further analyzed this variation through molecular dynamics which predicts that changes in flexibility of MYO3A structure would influence the protein-ATP binding properties. This Lys50Arg mutation segregated with congenital profound non-syndromic HI. To better investigate this variability, we collected previously identified MYO3A-KDs variants, p.(Tyr129Cys), p.(His142Gln) and p.(Pro189Thr), and built both wild type and mutant 3 D MYO3A-KD models to assess their impact on the protein structure and function. Our results suggest that KD mutations could either cause a congenital profound form of HI, when particularly affecting the kinase activity and preventing the auto-phosphorylation of the motor, or a late onset and progressive form, when partially or completely inactivating the MYO3A protein. In conclusion, we report a novel pathogenic variant affecting the ATP-binding site within the MYO3A-KD causing congenital profound HI. Through computational approaches we provide a deeper understanding on the correlation between the effects of MYO3A-KD mutations and the variable hearing phenotypes. To the best of our knowledge this is the first study to correlate mutations' genotypes with the variable phenotypes of DFNB30.Communicated by Ramaswamy H. Sarma.

The ATPase mechanism of myosin 15, the molecular motor mutated in DFNB3 human deafness

Identification of a Novel Homozygous Mutation in the MYO15A Gene in a Kazakh Family with Non-Syndromic Hearing Loss

Deafness mutation in the MYO3A motor domain impairs actin protrusion elongation mechanism

Asymmetrical Effects Of Deafness-Associated Mitochondrial Dna 7516dela Mutation On The Processing Of Rnas In The H-Strand And L-Strand Polycistronic Transcripts

Biochemical Characterization of the Mitochondrial Trnaser(ucn) T7511C Mutation Associated with Nonsyndromic Deafness

Functional Characterization of the Mitochondrial 12S Rrna C1494T Mutation Associated with Aminoglycoside-Induced and Non-Syndromic Hearing Loss.

Isolation and Characterization of the Putative Nuclear Modifier Gene MTO1 Involved in the Pathogenesis of Deafness-associated Mitochondrial 12 S rRNA A1555G Mutation

Defects in Mitochondrial Ribosomal Biogenesis Cause Sensorineural Deafness

A Novel Mutation Located in the N-Terminal Domain of MYO15A Caused Sensorineural Hearing Loss.

Myosin XVA: Dancing at the Tips of the Stereocilia

Nuclear Background Determines Biochemical Phenotype in the Deafness-Associated Mitochondrial 12s Rrna Mutation

Mitochondrial Stress Engages E2F1 Apoptotic Signaling to Cause Deafness

The dynamics of actin protrusions can be controlled by tip-localized myosin motors

MYO3A Causes Human Dominant Deafness and Interacts with Protocadherin 15-CD2 Isoform

Characterization of a novel MYO3A missense mutation associated with a dominant form of late onset hearing loss

A mouse model for human hearing loss DFNB30 due to loss of function of myosin IIIA

Select autosomal dominant DFNA11 deafness mutations activate Myo7A in epithelial cells

Identification and Functional Study of a New Missense Mutation in the Motor Head Domain of Myosin VIIA in a Family with Autosomal Dominant Hearing Impairment (DFNA11).

Functional and Developmental Changes in the Inner Hair Cell Ribbon Synapses Caused by Myosin VI Knockout and Deafness-Inducing Point Mutation

Myosin XVA isoforms participate in the mechanotransduction-dependent remodeling of the actin cytoskeleton in auditory stereocilia

Molecular insights into MYO3A kinase domain variants explain variability in both severity and progression of DFNB30 hearing impairment